MedTrace Logo

Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections

NCT04747171 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2021-02-10

No results posted yet for this study

Summary

we designed this randomized, single -blind, prospective clinical study to test postoperative analgesia of three intrathecal additives in elective caesarean sections which are magnesium, dexamethasone and dexmedetomidine.

Conditions

  • Pain, Postoperative

Interventions

DRUG

intrathecal Magnesium

intrathecal adjuvants to bupivacaine

DRUG

intrathecal dexamthasone

intrathecal adjuvants to bupivacaine

DRUG

intrathecal dexmedetomidine

intrathecal adjuvants to bupivacaine

Sponsors & Collaborators

  • Benha University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2021-06-30
Completion
2021-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04747171 on ClinicalTrials.gov